Drug intelligence / Profile preview

CelleRx

Development stage: Unknown
Lead developer: NovaBay Pharmaceuticals
Modality: Small Molecules
Administration: Topical

Overview

CelleRx is an **FDA-cleared prescription-grade skincare solution** for cleansing and reducing bacterial buildup on facial skin and wounds. Its active ingredient is **hypochlorous acid (HOCl)**, a molecule naturally produced by the human immune system to fight infection and facilitate wound healing. Unlike bleach-based or alcohol-based cleansers, CelleRx uses a pure HOCl formulation to maintain the skin barrier, making it suitable for use on sensitive skin, after aesthetic procedures, and to prevent infection or irritation due to acne, rosacea, or mask use. It is designed to gently disinfect and reset the skin without irritation, and is marketed as the only bleach-free HOCl product of its kind for cosmetic and medical use.

Brand names: CelleRx
Other names: CelleRx Clinical Reset

Beyond the preview

Go deeper on CelleRx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CelleRx.

Explore the full profile